论文部分内容阅读
目的观察孟鲁司特钠β2激动剂(美普清)治疗儿童咳嗽变异性型哮喘的疗效。方法80例患儿随机分成两组,治疗组给以孟鲁司特钠及美普清。对照组服用美普清。结果两组临床疗效比较,治疗组有效率90%,对照组有效率75%,经统计学处理,具有显著性差异P<0.05。结论加用孟鲁司特钠治疗儿童咳嗽变异型哮喘,疗效明显,安全性高,未发生不良反应。
Objective To observe the efficacy of montelukast sodium β2 agonist (Meipu Qing) in treating children with cough variant asthma. Methods Eighty children were randomly divided into two groups. The treatment group was given montelukast sodium and metoprolol. The control group took Meipuqing. Results The clinical efficacy of the two groups was 90% in the treatment group and 75% in the control group, with statistical significance (P <0.05). Conclusion Adding montelukast sodium in children with cough variant asthma has obvious curative effect, high safety and no adverse reactions.